Search Results - "Reyes, Diane K."

Refine Results
  1. 1

    The biology and treatment of oligometastatic cancer by Reyes, Diane K, Pienta, Kenneth J

    Published in Oncotarget (20-04-2015)
    “…Clinical reports of limited and treatable cancer metastases, a disease state that exists in a transitional zone between localized and widespread systemic…”
    Get full text
    Journal Article
  2. 2

    Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma by PAWLIK, Timothy M, REYES, Diane K, COSGROVE, David, KAMEL, Ihab R, BHAGAT, Nikhil, GESCHWIND, Jean-Francois H

    Published in Journal of clinical oncology (20-10-2011)
    “…PURPOSE To evaluate safety and efficacy of combined transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEB) and sorafenib in patients with…”
    Get full text
    Journal Article
  3. 3
  4. 4

    RNA profiling of circulating tumor cells systemically captured from diagnostic leukapheresis products in prostate cancer patients by Dong, Liang, Du, Xinxing, Lu, Changxue, Zhang, Zhongyuan, Huang, Chung-Ying, Yang, Lei, Warren, Sarah, Kuczler, Morgan D., Reyes, Diane K., Luo, Jun, Amend, Sarah R., Xue, Wei, Pienta, Kenneth J.

    Published in Materials today bio (15-12-2022)
    “…The application of circulating tumor cells (CTCs) in both clinical practice and research has been continuously limited by the rare number of targets that can…”
    Get full text
    Journal Article
  5. 5
  6. 6

    PSMA-targeted [18F]DCFPyL PET/CT-avid lesions in a patient with prostate cancer: Clinical decision-making informed by the PSMA-RADS interpretive framework by Reyes, Diane K., Demehri, Shadpour, Werner, Rudolf A., Pomper, Martin G., Gorin, Michael A., Rowe, Steven P., Pienta, Kenneth J.

    Published in Urology case reports (01-03-2019)
    “…We present the case of a man with oligometastatic prostate cancer who underwent a PSMA-targeted 18F-DCFPyL PET/CT scan in order to illustrate how the PSMA-RADS…”
    Get full text
    Journal Article
  7. 7

    CT‐based assessment of body composition following neoadjuvant chemohormonal therapy in patients with castration‐naïve oligometastatic prostate cancer by Sheikhbahaei, Sara, Reyes, Diane K., Rowe, Steven P., Pienta, Kenneth J.

    Published in The Prostate (01-02-2021)
    “…Background The purpose of this study is to assess the body composition changes in men with recently diagnosed oligometastatic prostate cancer following…”
    Get full text
    Journal Article
  8. 8

    Peripheral androgen blockade in men with castrate-sensitive biochemical recurrent prostate cancer by Reyes, Diane K., Pienta, Kenneth J.

    “…The aim of the study was to evaluate the feasibility of utilizing peripheral androgen blockade in men with biochemical recurrent castrate-sensitive prostate…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Oligometastatic Prostate Cancer to the Navicular Bone: Case Report by Reyes, Diane K., Miller, James A., Cerrato, Rebecca A., Pienta, Kenneth J.

    Published in Urology case reports (01-05-2015)
    “…This case of oligometastatic prostate cancer to the foot highlights the importance of: 1) metastasis remaining high in the differential for unexplained malady,…”
    Get full text
    Journal Article
  11. 11

    Unresectable Hepatocellular Carcinoma: Serial Early Vascular and Cellular Changes after Transarterial Chemoembolization as Detected with MR Imaging by KAMEL, Ihab R, LIAPI, Eleni, REYES, Diane K, ZAHURAK, Marianna, BLUEMKE, David A, GESCHWIND, Jean-François H

    Published in Radiology (01-02-2009)
    “…To prospectively assess serial changes in contrast material-enhanced and diffusion-weighted (DW) magnetic resonance (MR) imaging values within 1 month after…”
    Get full text
    Journal Article
  12. 12

    Phase II Study of Chemoembolization With Drug-Eluting Beads in Patients With Hepatic Neuroendocrine Metastases: High Incidence of Biliary Injury by Bhagat, Nikhil, Reyes, Diane K., Lin, Mingde, Kamel, Ihab, Pawlik, Timothy M., Frangakis, Constantine, Geschwind, J. F.

    “…Purpose To evaluate safety in an interim analysis of transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEB) in 13 patients with hepatic…”
    Get full text
    Journal Article
  13. 13

    Comparison of quantitative Y-90 SPECT and non-time-of-flight PET imaging in post-therapy radioembolization of liver cancer by Yue, Jianting, Mauxion, Thibault, Reyes, Diane K., Lodge, Martin A., Hobbs, Robert F., Rong, Xing, Dong, Yinfeng, Herman, Joseph M., Wahl, Richard L., Geschwind, Jean-François H., Frey, Eric C.

    Published in Medical physics (Lancaster) (01-10-2016)
    “…Purpose: Radioembolization with yttrium-90 microspheres may be optimized with patient-specific pretherapy treatment planning. Dose verification and validation…”
    Get full text
    Journal Article
  14. 14

    Open-Label Single-Arm Phase II Trial of Sorafenib Therapy with Drug-eluting Bead Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma: Clinical Results by Cosgrove, David P, Reyes, Diane K, Pawlik, Timothy M, Feng, Allen L, Kamel, Ihab R, Geschwind, Jean-François H

    Published in Radiology (01-11-2015)
    “…To determine the efficacy of combined continuous sorafenib therapy and drug-eluting bead (DEB) transarterial chemoembolization (TACE) in patients with…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma by Kamel, Ihab R, Bluemke, David A, Eng, John, Liapi, Eleni, Messersmith, Wells, Reyes, Diane K, Geschwind, Jean-Francois H

    “…To assess treatment response of hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE) with use of diffusion and dynamic contrast…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma by Buijs, Manon, Reyes, Diane K., Pawlik, Timothy M., Blackford, Amanda L., Salem, Riad, Messersmith, Wells A., Weekes, Colin D., Mulcahy, Mary, Kamel, Ihab R., Geschwind, Jean‐Francois H.

    Published in Cancer (01-03-2013)
    “…BACKGROUND: Vascular endothelial growth factor is up‐regulated in hepatocellular carcinoma (HCC) and is further up‐regulated after transhepatic arterial…”
    Get full text
    Journal Article
  20. 20